EMT in cancer is generally marked by transcriptional downregulation of epithelial markers, including E-cadherin, and upregulation of mesenchymal markers, including N-cadherin and vimentin, via activity of the transcription factors, including Twist-1, Snail, and ZEB1 [22]. The gene discussed is ZEB1; the disease is cancer.